[
  {
    "ts": null,
    "headline": "A Fresh Look at Bristol-Myers Squibb (BMY) Valuation After Recent Share Price Rebound",
    "summary": "Bristol-Myers Squibb (BMY) shares have seen mixed movement over the past month, with the stock rebounding nearly 9% but still trading below this year’s highs. Investors continue to monitor the company’s performance trends and financials. See our latest analysis for Bristol-Myers Squibb. Even after this month’s strong 8.9% share price return, Bristol-Myers Squibb is still trying to regain its footing following a tough year for total shareholders, who are down nearly 15%. While short-term...",
    "url": "https://finnhub.io/api/news?id=63378d05a2f865740047c9590a861713bed579b08feb6c34092609f58cd39a86",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764101682,
      "headline": "A Fresh Look at Bristol-Myers Squibb (BMY) Valuation After Recent Share Price Rebound",
      "id": 137611508,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb (BMY) shares have seen mixed movement over the past month, with the stock rebounding nearly 9% but still trading below this year’s highs. Investors continue to monitor the company’s performance trends and financials. See our latest analysis for Bristol-Myers Squibb. Even after this month’s strong 8.9% share price return, Bristol-Myers Squibb is still trying to regain its footing following a tough year for total shareholders, who are down nearly 15%. While short-term...",
      "url": "https://finnhub.io/api/news?id=63378d05a2f865740047c9590a861713bed579b08feb6c34092609f58cd39a86"
    }
  },
  {
    "ts": null,
    "headline": "BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi",
    "summary": "Bristol Myers wins EC approval to expand Breyanzi's label, adding MCL patients to its growing roster of European CAR-T indications.",
    "url": "https://finnhub.io/api/news?id=58762239f9e3a404d6f59494acb6333f47cfb175f789b1bd360b1f9dbeee9a22",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764097260,
      "headline": "BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi",
      "id": 137611250,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers wins EC approval to expand Breyanzi's label, adding MCL patients to its growing roster of European CAR-T indications.",
      "url": "https://finnhub.io/api/news?id=58762239f9e3a404d6f59494acb6333f47cfb175f789b1bd360b1f9dbeee9a22"
    }
  },
  {
    "ts": null,
    "headline": "Legend Biotech: Is Carvykti Changing Cancer Treatment Forever?",
    "summary": "Discover why Legend Biotech is rated a 'Strong Buy' as rising Carvykti sales drive growth.",
    "url": "https://finnhub.io/api/news?id=5a5fd84f432763684966abcc7afa84169707557fd4625c77c5b3e5f1fb0f32f8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764081506,
      "headline": "Legend Biotech: Is Carvykti Changing Cancer Treatment Forever?",
      "id": 137606292,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1924268149/image_1924268149.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Discover why Legend Biotech is rated a 'Strong Buy' as rising Carvykti sales drive growth.",
      "url": "https://finnhub.io/api/news?id=5a5fd84f432763684966abcc7afa84169707557fd4625c77c5b3e5f1fb0f32f8"
    }
  },
  {
    "ts": null,
    "headline": "Bayer Resurrects Scrapped Blood-Thinning Drug as Breakthrough Stroke Treatment",
    "summary": "The trial proved so successful that Bayer plans to reach out to regulators in preparation for submitting the drug candidate for approval.",
    "url": "https://finnhub.io/api/news?id=e60775d825bc07ed9061f399c101c0bc6997bad6a58e91a84a26d48f05888360",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764070200,
      "headline": "Bayer Resurrects Scrapped Blood-Thinning Drug as Breakthrough Stroke Treatment",
      "id": 137605806,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "The trial proved so successful that Bayer plans to reach out to regulators in preparation for submitting the drug candidate for approval.",
      "url": "https://finnhub.io/api/news?id=e60775d825bc07ed9061f399c101c0bc6997bad6a58e91a84a26d48f05888360"
    }
  }
]